An evaluation of the impact of persistence to oral antidiabetic medication on reducing the risk of hospitalization in adult patients with type 2 diabetes.
Antonio P. Legorreta, MD, MPH
Advertisement
Articles by Antonio P. Legorreta, MD, MPH
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves First-in-Class Daraxonrasib for Metastatic Pancreatic Cancer
2
FDA Grants Fast Track Designation to CK0803 for Amyotrophic Lateral Sclerosis
3
Yeast-Based Universal Flu Vaccine Fully Protects Mice Against 3 Influenza Strains
4
What Pharmacists Should Know About Novo Nordisk-Eli Lilly GLP-1 Ad Suit
5